FTAHX | RITCX | FTAHX / RITCX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 4 years | 23 years | - |
Gain YTD | 9.310 | 8.732 | 107% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250 | 250 | 100% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 22.6B | 22.6B | 100% |
Annual Yield % from dividends | 6.76 | 6.20 | 109% |
Returns for 1 year | 9.99 | 9.36 | 107% |
Returns for 3 years | 12.40 | 10.45 | 119% |
Returns for 5 years | N/A | 27.66 | - |
Returns for 10 years | N/A | 57.83 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
HMECX | 18.74 | 0.01 | +0.05% |
NexPoint Merger Arbitrage C | |||
CVSCX | 15.22 | N/A | N/A |
Calamos Market Neutral Income C | |||
MVGNX | 16.62 | -0.03 | -0.18% |
MFS Low Volatility Global Equity R6 | |||
LYFAX | 12.69 | -0.07 | -0.55% |
AlphaCentric Life Sciences & Hlthcare A | |||
TQCAX | 18.26 | -0.12 | -0.65% |
Touchstone Dividend Equity A |